Erschienen in:
01.08.2014 | Head and Neck
Feasibility of high-resolution pituitary MRI at 7.0 tesla
verfasst von:
Alexandra A. J. de Rotte, Anja G. van der Kolk, Dik Rutgers, Pierre M. J. Zelissen, Fredy Visser, Peter R. Luijten, Jeroen Hendrikse
Erschienen in:
European Radiology
|
Ausgabe 8/2014
Einloggen, um Zugang zu erhalten
Abstract
Objectives
Since the pituitary gland measures 3-8 mm, imaging with the highest possible spatial resolution is important for the detection of even smaller lesions such as those seen in Cushing's disease. In the current feasibility study, we tested a multi-sequence MRI protocol to visualize the pituitary gland in high resolution at 7.0 Tesla (7.0 T).
Methods
Ten healthy volunteers were examined with a 7.0 T pituitary gland protocol. The protocol consisted of a T1-weighted magnetization-prepared inversion recovery (MPIR) turbo spin-echo (TSE) sequence and a T2-weighted TSE sequence. Additionally, this protocol was tested in five patients with clinical and biochemical suspicion of a microadenoma.
Results
The dedicated protocol was successful in visualizing normal pituitary anatomy. At 7.0 T compared to 1.5 T, four times as many slices covered the pituitary gland in sagittal and coronal direction. In three patients, a lesion was diagnosed at 7.0 T, and was confirmed by histopathology to be a microadenoma.
Conclusion
Head-to-head comparisons of 7.0 T with 1.5 T and 3.0 T are needed with larger samples of patients and with imaging times feasible for clinical settings. However, the current study suggests that high-resolution 7.0 T MRI of the pituitary gland may provide new perspectives when used as a second-line diagnostic examination in the specific context of Cushing's disease.
Key Points
• 7.0 T MRI enables ultra-high-resolution imaging of the pituitary gland.
• 7.0 T MRI is appropriate to visualize normal pituitary gland anatomy.
• The pituitary protocol consists of a T
1
-MPIR-TSE and a T
2
-TSE sequence.
• In four patients, a suspected ACTH-producing microadenoma was visualized at 7.0 T.
• Histopathology confirmed three of four lesions to be ACTH-producing microadenomas.